Results 241 to 250 of about 10,302,641 (371)
Aberrant SUMOylation Restricts the Targetable Cancer Immunopeptidome
Pharmacological SUMOylation inhibition (SUMOi) counteracts tumor immune evasion by unmasking an immunogenic HLA‐I peptide and neoepitope repertoire. By restoring HLA‐I ligand availability through increased antigen processing and presentation, enhanced proteasomal cleavage, and modulated TAP1 peptide affinity, SUMOi boosts tumor immunogenicity ...
Uta M. Demel +19 more
wiley +1 more source
Next-Generation Sequencing: An Advanced Diagnostic Tool for Detection of Pancreatic Disease/Disorder. [PDF]
Biswas S +6 more
europepmc +1 more source
Application of minimally invasive technique in surgical treatment of pancreatic diseases
Yixi Zhang
openalex +2 more sources
Measurement of trypsin and chymotrypsin activity in stools to detect chronic pancreatic disease [PDF]
John G. Banwell +2 more
openalex +1 more source
Elemene increases SPP expression by competitively binding with miR‐130a‐5p to suppress SPP mRNA degradation. This led to more antigen/MHC‐I complexes being expressed on the cell surface, which consequently facilitated the recognition and killing of HCC cells by CTLs and enhancing the antitumor immune efficacy of anti‐PD‐1.
Menglan Wang +18 more
wiley +1 more source
Mitochondrial uncoupling protein 2: a central player in pancreatic disease pathophysiology. [PDF]
Wang K +5 more
europepmc +1 more source
Cytokeratin-positive cells in the bone marrow from patients with pancreatic, periampullary malignancy and benign pancreatic disease show no prognostic information. [PDF]
Hugenschmidt H +9 more
europepmc +1 more source
Bactibilia-effect on postoperative course and outcome in patients with bilio-pancreatic diseases
A. Dinakar Reddy +2 more
openalex +2 more sources

